hoe 33342 and abt-737
hoe 33342 has been researched along with abt-737 in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
An, J; Huang, Z; Mao, Y; Xu, Y; Yang, S; Zhang, H | 1 |
Curran, WJ; Deng, X; Khuri, FR; Li, R; Magis, AT; Owonikoko, TK; Park, D; Ramalingam, SS; Sica, GL; Sun, SY | 1 |
Reviews
1 review(s) available for hoe 33342 and abt-737
Article | Year |
---|---|
The chemical biology of apoptosis: Revisited after 17 years.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Design; Humans; Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2019 |
Other Studies
1 other study(ies) available for hoe 33342 and abt-737
Article | Year |
---|---|
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
Topics: Acridines; Aminopyridines; Animals; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-X Protein; Benzimidazoles; Biphenyl Compounds; Blotting, Western; Cell Proliferation; Cytochromes c; Female; Humans; Lung; Lung Neoplasms; Mice; Mice, Nude; Nitrophenols; Piperazines; Protein Multimerization; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Radiation, Ionizing; Small Molecule Libraries; Sulfonamides; Survival Rate | 2013 |